SEC Form 4 · accession 0001140361-15-028270
BIOMARIN PHARMACEUTICAL INC · BMRN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jeffrey Robert Ajer
Officer — SVP, Chief Commercial Of
Period of report
Jul 20, 2015
Accepted (ET)
Jul 22, 2015 · 3:21 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001048477
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Jul 20, 2015 | M | 3,000 | $63.10 | A | 38,605 | D | |
| Common StockF1,F2 | Jul 20, 2015 | S | 3,000 | $150.00 | D | 35,605 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) Common StockF4,F3 | $63.10 | Jul 20, 2015 | M | 3,000 | D | Dec 4, 2014 | Jun 3, 2024 | Common Stock | 3,000 | 39,700 | D |
Explanation of responses
- F1Trade made pursuant to a 10b5-1 plan executed Mayy 11, 2015
- F2All shares sold at the same price
- F3Original option grant vests 6/48ths on December 4, 2014 and 1/48th on the 4th fay of ever month thereafter.
- F4Reflects the number of stock options that remain outstanding from this specific stock option grant following the reported transactions.